Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2015 Filed Jan 6, 2015 21:48 UTC SaleCommon Stock 100 $118.91 $11,891.00
Disclosure

SEC source: 0001209191-15-002257 · doc4.xml · nonDerivative · entry 2

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,165

F1 · kind: Transaction made pursuant to Ms. Ullian's company approved trading plan under Rule 10b5-1.

Read SEC document
January 02, 2015 Filed Jan 6, 2015 21:48 UTC Exercise / conversionCommon Stock 5,000 $34.32 $171,600.00
Disclosure

SEC source: 0001209191-15-002257 · doc4.xml · nonDerivative · entry 1

ULLIAN ELAINE · CIK 0001190290 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · derivative · entry 12

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 547,200

Underlying: Common Stock · 4,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,300 $0.00 Strike: $17.16 $0.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · derivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,900

Underlying: Common Stock · 1,300 shares

Expires 2015-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,800 $0.00 Strike: $10.41 $0.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · derivative · entry 10

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,388

Underlying: Common Stock · 4,800 shares

Expires 2015-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC SaleCommon Stock 400 $121.80 $48,720.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,895

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $121.80 (range $121.79 to $121.80).

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC SaleCommon Stock 3,200 $121.10 $387,520.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,295

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $121.10 (range $120.79 to $121.43).

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC SaleCommon Stock 4,900 $120.38 $589,862.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 342,495

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $120.38 (range $119.78 to $120.77).

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC SaleCommon Stock 2,000 $119.32 $238,640.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,395

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $119.32 (range $118.78 to $119.69).

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionCommon Stock 4,400 $35.64 $156,816.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionCommon Stock 1,300 $17.16 $22,308.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2014 Filed Jan 5, 2015 21:29 UTC Exercise / conversionCommon Stock 4,800 $10.41 $49,968.00
Disclosure

SEC source: 0001209191-15-000974 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · derivative · entry 14

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 551,600

Underlying: Common Stock · 4,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,300 $0.00 Strike: $17.16 $0.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · derivative · entry 13

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,200

Underlying: Common Stock · 1,300 shares

Expires 2015-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,800 $0.00 Strike: $10.41 $0.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · derivative · entry 12

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,188

Underlying: Common Stock · 4,800 shares

Expires 2015-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 400 $121.67 $48,668.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,895

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $121.67 (range $121.64 to $121.76).

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 600 $120.78 $72,468.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,295

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $120.78 (range $120.15 to $121.11).

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 500 $119.33 $59,665.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 339,895

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $119.33 (range $119.12 to $119.39).

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 900 $118.22 $106,398.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,395

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $118.22 (range $118.06 to $118.63).

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 4,570 $117.44 $536,700.80
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 341,295

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $117.44 (range $117.00 to $117.98).

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC SaleCommon Stock 3,530 $116.56 $411,456.80
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,865

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $116.56 (range $116.00 to $116.97).

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionCommon Stock 4,400 $35.64 $156,816.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionCommon Stock 1,300 $17.16 $22,308.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 22, 2014 Filed Dec 23, 2014 23:06 UTC Exercise / conversionCommon Stock 4,800 $10.41 $49,968.00
Disclosure

SEC source: 0001209191-14-077827 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · derivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 556,000

Underlying: Common Stock · 4,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,300 $0.00 Strike: $17.16 $0.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · derivative · entry 10

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,500

Underlying: Common Stock · 1,300 shares

Expires 2015-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,800 $0.00 Strike: $10.41 $0.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,988

Underlying: Common Stock · 4,800 shares

Expires 2015-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC SaleCommon Stock 1,700 $112.05 $190,485.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 338,895

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $112.05 (range $111.69 to $112.35).

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC SaleCommon Stock 2,800 $111.13 $311,164.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 340,595

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $111.13 (range $110.66 to $111.58).

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC SaleCommon Stock 6,000 $110.04 $660,240.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,395

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $110.04 (range $109.64 to $110.51).

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionCommon Stock 4,400 $35.64 $156,816.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionCommon Stock 1,300 $17.16 $22,308.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 344,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 17, 2014 Filed Dec 19, 2014 21:15 UTC Exercise / conversionCommon Stock 4,800 $10.41 $49,968.00
Disclosure

SEC source: 0001209191-14-076990 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 200 $120.17 $24,034.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 9

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,677

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 200 $119.00 $23,800.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 8

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,877

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 2,700 $118.05 $318,735.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 7

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 218,077

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $118.05 (range $117.74 to $118.64).

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 8,650 $117.26 $1,014,299.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 6

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 220,777

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $117.26 (range $116.74 to $117.73).

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 3,400 $116.27 $395,318.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 5

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 229,427

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $116.27 (range $115.73 to $116.70).

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 6,406 $115.05 $737,010.30
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 4

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 232,827

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $115.05 (range $114.69 to $115.68).

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 15,440 $114.21 $1,763,402.40
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 3

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 239,233

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $114.21 (range $113.66 to $114.65).

Read SEC document
December 15, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
SaleCommon Stock 13,021 $113.19 $1,473,846.99
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 2

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,673

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $113.19 (range $112.66 to $113.65).

F4 · price: Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:06 UTC
Connolly ThomasSVP, Human Resources
SaleCommon Stock 220 $120.50 $26,510.00
Disclosure

SEC source: 0001209191-14-075834 · doc4.xml · nonDerivative · entry 2

Connolly Thomas · CIK 0001453943 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,375

F1 · kind: Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $120.50 (range $120.45 to $120.57).

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:06 UTC
Connolly ThomasSVP, Human Resources
SaleCommon Stock 300 $119.73 $35,919.00
Disclosure

SEC source: 0001209191-14-075834 · doc4.xml · nonDerivative · entry 1

Connolly Thomas · CIK 0001453943 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,595

F1 · kind: Transaction made pursuant to Mr. Connolly's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $119.73 (range $119.31 to $120.25).

F3 · price: Mr. Connolly undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:09 UTC
Silva Paul MSVP & Corp Controller
SaleCommon Stock 1,100 $120.48 $132,528.00
Disclosure

SEC source: 0001209191-14-075839 · doc4.xml · nonDerivative · entry 2

Silva Paul M · CIK 0001446372 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,187

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $120.48 (range $120.28 to $120.84).

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:09 UTC
Silva Paul MSVP & Corp Controller
SaleCommon Stock 1,713 $119.82 $205,251.66
Disclosure

SEC source: 0001209191-14-075839 · doc4.xml · nonDerivative · entry 1

Silva Paul M · CIK 0001446372 · SVP & Corp Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,287

F1 · kind: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $119.82 (range $119.20 to $120.19).

F3 · price: Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:11 UTC
SMITH IAN FEVP & CFO
SaleCommon Stock 2,880 $120.44 $346,867.20
Disclosure

SEC source: 0001209191-14-075844 · doc4.xml · nonDerivative · entry 2

SMITH IAN F · CIK 0001197032 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 113,826

F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $120.44 (range $120.22 to $120.84).

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:11 UTC
SMITH IAN FEVP & CFO
SaleCommon Stock 3,162 $119.82 $378,870.84
Disclosure

SEC source: 0001209191-14-075844 · doc4.xml · nonDerivative · entry 1

SMITH IAN F · CIK 0001197032 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,706

F1 · kind: Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $119.82 (range $119.21 to $120.20).

F3 · price: Mr. Smith undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
December 12, 2014 Filed Dec 16, 2014 21:14 UTC
LEIDEN JEFFREY MDirector · CEO & President
GiftCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-14-075849 · doc4.xml · nonDerivative · entry 1

LEIDEN JEFFREY M · CIK 0001242825 · Director · CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,694

F1 · kind: Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.

F2 · shares: Represents a gift made to a charitable donor-advised fund.

Read SEC document
December 10, 2014 Filed Dec 12, 2014 21:21 UTC Exercise / conversionStock Option (right to buy) · Derivative 4,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-14-074984 · doc4.xml · derivative · entry 13

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 560,400

Underlying: Common Stock · 4,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Fully vested.

Read SEC document
December 10, 2014 Filed Dec 12, 2014 21:21 UTC Exercise / conversionStock Option (right to buy) · Derivative 1,300 $0.00 Strike: $17.16 $0.00
Disclosure

SEC source: 0001209191-14-074984 · doc4.xml · derivative · entry 12

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,800

Underlying: Common Stock · 1,300 shares

Expires 2015-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_date: Fully vested.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.